Navigation Links
Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Date:11/12/2009

BASKING RIDGE, N.J., Nov. 12 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, November 17 and will include an overview of the Company's pipeline with emphasis on the lead development program, the anticoagulant system, REG1. This conference is well attended and will include several hundred institutional investors with more than one hundred healthcare management teams presenting.

ABOUT REGADO BIOSCIENCES

Regado Biosciences is pioneering a new therapeutic technology with the creation and development of two-component drug systems. Each system comprises a nuclease-stabilized RNA aptamer that can be controlled directly by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics, including anticoagulants and antiplatelet agents, a multi-billion dollar market in need of therapeutics with improved safety profiles and a greater degree of therapeutic control. Regado's technology is designed to give physicians the ability to actively and directly control each system's therapeutic effect providing a safe and unique approach to personalized medicine.

ABOUT REG1 and REG2

Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents both administered by IV bolus, the first being a potent highly selective Factor IXa inhibitor (RB006) and the second being its complementary active control agent (RB007). RB007 can be used to selectively completely or partially reverse the anticoagulant effect of RB006. REG1, presently in phase 2b clinical trial, is intended for application in
'/>"/>

SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
2. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
3. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
4. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
5. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
6. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
7. Regado Biosciences Establishes Medical Advisory Board
8. Regado Biosciences Expands Medical Advisory Board
9. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
10. Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009
11. Regado Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2009 on September 11, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 More than 5 million ... 1 in 3 seniors will die with Alzheimer’s or ... jaw-dropping figures have shocked many Americans into looking for ... prevent these tragic age-related cognitive disorders. Jonathan Weisman, president ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... RESEARCH TRIANGLE PARK, N.C., April 18 The ... Hamner Institutes for Health,Sciences have signed a memorandum ... and translational research., Established with Carolina,s schools ... Business School, this unique partnership,capitalizes on the scientific ...
... Authorizing DNA Testing of Federal Arrestees Expected ... Ability to Combat Crime - - Complements Recent Moves ... N.J., April 18 Orchid Cellmark,Inc. (Nasdaq: ORCH ), ... new federal regulations previewed by the U.S.,Justice Department that are ...
... April 18 MED3OOO Group, Inc. (MED3OOO), ... Pathology,Consultants, Inc. of Michigan City, IN, recently ... of MED3OOO -- for billing, marketing, and ... a twenty-physician pathology practice,providing services to a ...
Cached Biology Technology:UNC-Chapel Hill, Hamner Institutes Announce Partnership to Accelerate Basic, Translational Research 2Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees 2Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees 3Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees 4Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees 5Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 2Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 3
(Date:4/18/2014)... A team of researchers led by a University of ... receive a $7.5 million Department of Defense grant to ... scientific foundations for the predictable design of light-weight, tough ... of structures from plants and animals, including the mantis ... biological systems have constructed over millions of years and ...
(Date:4/17/2014)... A drug under clinical trials to treat tuberculosis ... drugs that act against various bacteria, fungal infections and ... University of Illinois chemists and collaborators. , Led by ... determined the different ways the drug SQ109 attacks the ... target other pathogens from yeast to malaria and ...
(Date:4/17/2014)... Information about archaeological remains of ancient chili peppers in ... words for chili peppers in ancient dialects helped researchers ... value of multi-proxy data analysis. Their results are from ... in a special feature issue of the Proceedings ... and animal domestication edited by Dolores Piperno, staff scientist ...
Breaking Biology News(10 mins):Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3
... at work in protein production, a Princeton-led team has ... In doing so, they also have discovered how one ... natural cancer-fighting process. In a study appearing in ... , Thomas Silhavy, Princeton,s Warner-Lambert Parke-Davis Professor of Molecular ...
... the University of Oklahoma Health Sciences Center have shown the ... blood pressure. The results, which appear this month in the ... age and how we might live longer. Persistent hypertension, ... heart attack, heart failure, arterial aneurysm and is the leading ...
... weeks, Amanda Cobbs-Russell, a junior majoring in conservation biology ... a lifetime, requiring her to push herself to her physical ... people two Americans and three Canadians selected from ... and sleep among sweeping glaciers, polar ice and jagged granite ...
Cached Biology News:Princeton team learns why some drugs pack such a punch 2Princeton team learns why some drugs pack such a punch 3Anti-aging gene linked to high blood pressure 2UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 2UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 3
Control primers and template for 5kb and 15 kb products....
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
A formulation of our Biolase DNA Polymerase which contains a Red Loading Dye...
Biology Products: